ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding ARS Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 72 | −1 |
| Shares | 28.9M | 162.2K | 30.1M | +1.37M (+4.8%) |
| Value | $288.4M | $1.62M | $200.5M | −$86.3M (−30.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nextech Invest AG | 1,910,029 | $12.7M | 3.35% |
| Ensign Peak Advisors, Inc | 409,975 | $2.73M | 0.01% |
| Price T Rowe Associates Inc | 299,674 | $2.00M | 0.00% |
| Endurant Capital Management LP | 84,295 | $561.0K | 0.15% |
| Acadian Asset Management LLC | 78,634 | $522.0K | 0.00% |
| Nomura Holdings Inc | 68,639 | $461.0K | 0.00% |
| Prosight Management, LP | 53,815 | $358.0K | 0.24% |
| Parametric Portfolio Associates LLC | 40,518 | $270.0K | 0.00% |
| Bailard, Inc. | 32,000 | $213.0K | 0.01% |
| Virtu Financial LLC | 20,317 | $135.0K | 0.01% |
| ExodusPoint Capital Management, LP | 19,148 | $128.0K | 0.00% |
| XTX Topco Ltd | 18,816 | $125.0K | 0.07% |
| Prelude Capital Management, LLC | 16,700 | $111.0K | 0.01% |
| Quattro Financial Advisors LLC | 12,869 | $86.0K | 0.03% |
| Gsa Capital Partners LLP | 11,591 | $77.0K | 0.01% |
| Quantbot Technologies LP | 7,921 | $52.0K | 0.00% |
| Eagle Bay Advisors LLC | 5,930 | $42.0K | 0.03% |
| Simplex Trading, LLC | 2,147 | $14.0K | 0.00% |
| Toronto Dominion Bank | 2 | $0 | 0.00% |
Sold out (20)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Boxer Capital, LLC | 1,675,377 | $16.7M |
| Marshall Wace, LLP | 275,567 | $2.75M |
| PFM Health Sciences, LP | 188,243 | $1.88M |
| 5AM Venture Management, LLC | 169,748 | $1.69M |
| Rhenman & Partners Asset Management AB | 150,000 | $1.50M |
| Pictet Asset Management SA | 119,551 | $1.19M |
| Commodore Capital LP | 97,143 | $969.0K |
| Walleye Capital LLC | 92,654 | $925.0K |
| Swiss National Bank | 23,100 | $231.0K |
| Man Group plc | 23,113 | $231.0K |
| Walleye Trading LLC | 18,956 | $189.0K |
| State of Wisconsin Investment Board | 16,500 | $165.0K |
| Squarepoint Ops LLC | 15,593 | $156.0K |
| Manufacturers Life Insurance Company, The | 13,766 | $137.0K |
| MetLife Investment Management | 9,098 | $90.8K |
| Virtus ETF Advisers LLC | 6,371 | $64.0K |
| Metropolitan Life Insurance Co | 6,383 | $63.7K |
| Point72 Hong Kong Ltd | 2,782 | $28.0K |
| Signaturefd, LLC | 66 | $1.00K |
| State of Wyoming | 14 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 162,183 | $1.62M |